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Abstract
Background: The incidence of skin and soft-tissue infections (SSTIs) has rapidly increased among
children in primary care settings since the emergence of community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA). Recent treatment recommendations emphasize CA-MRSA as
the primary cause, performing incision and drainage (I&D) as the primary therapy, and not
prescribing antibiotics for uncomplicated cases. It is unknown how this epidemic has impacted
primary care pediatricians in terms of their practice patterns and barriers they face to providing
recommended therapies.
Methods: 3 Focus groups among 29 primary care pediatricians in the San Francisco Bay Area were
conducted. Transcripts were reviewed and coded into major themes by two investigators using
modified grounded theory.
Results: Substantial changes in clinical practice have occurred since the emergence of CA-MRSA.
These include increased office visits for SSTIs, patients with multiple recurrences and transmission
within households. Additionally, our participants reported increased visits for mild skin problems
due to media reports contributing to fears about CA-MRSA. Participants routinely prescribed
antibiotics for SSTIs, however, few performed I&D. Few were aware of recent SSTI treatment
recommendations. Barriers to prescribing antibiotics with CA-MRSA activity included concerns
about side-effects and lack of local epidemiologic data showing that it is the primary etiology.
Barriers to performing I&D included lack of training, resources and skepticism about its necessity.
Important clinical challenges included increased time demands for follow-up visits and patient
education along with the lack of evidence-based strategies for preventing recurrent inections and
household transmission.
Conclusion: CA-MRSA has influenced the presentation and treatment of SSTIs especially in terms
of case numbers and recurrences. Barriers to providing recommended therapies can be addressed
through improved dissemination of treatment guidelines and epidemiologic data. Studies are
urgently needed toimprove theevidence-base for treatment and prevention strategies.
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Background
Community-associated methicillin-resistant Staphylococ-
cus aureus (CA-MRSA) first emerged among children in the
1990s [1]. Over the last decade, CA-MRSA has become the
predominant cause of purulent skin and soft-tissue infec-
tions (SSTIs) in the United States [2]. Although invasive
infections occur, SSTIs are the most common clinical
manifestation of CA-MRSA [3]. Coincident with this epi-
demic, the incidence of pediatric ambulatory visits for
SSTIs has nearly tripled, evidence that CA-MRSA has sig-
nificantly increased the health care burden of SSTIs [4].
Following a 2007 publication about the epidemiology of
invasive MRSA infections [5] and highly publicized deaths
of healthy adolescents, media attention to MRSA has
increased substantially [6].
Therapeutic options for SSTIs include antibiotic therapy
and incision and drainage (I&D). Recommendations
from both the Centers for Disease Control (CDC) [7,8]
and the American Academy of Pediatrics (AAP) [9]
emphasize performing I&D as the primary treatment,
sending purulent material for culture, not using antibiot-
ics for uncomplicated cases and targeting CA-MRSA when
empiric antibiotics are prescribed. These guidelines
assume that primary care physicians have a system to
monitor community epidemiology, track culture results
and have sufficient resources to perform I&D.
We hypothesized that the increased incidence, complexity
and public attention to CA-MRSA have placed a signifi-
cant burden on primary care pediatricians' practices. We
conducted focus groups with primary care pediatricians to
assess the impact of CA-MRSA on SSTI management and
to identify barriers to providing recommended therapies.
Methods
Study Design
Because the CA-MRSA epidemic is recent and the impact
on pediatricians is largely unknown, we used a qualitative
focus group design to obtain in-depth information
directly from the key stakeholders about their experience
and practice patterns for patients with purulent SSTIs. We
conducted three focus groups of primary care pediatric
practitioners in the San Francisco Bay Area to understand
the impact of CA-MRSA on the presentation and manage-
ment of purulent SSTIs. San Francisco is a city with
110,000 persons under age 18 and has a high prevalence
of CA-MRSA. A recent study incorporating laboratory data
from 8 of the 9 medical center laboratories in San Fran-
cisco estimated the annual CA-MRSA incidence as 316
cases per 100,000 population [10]. In San Francisco, CA-
MRSA is the predominant organism among cultured
abscesses (80% at the University of California, San Fran-
cisco pediatric clinic) [11,12] which mirrors national
trends [2]. The study was approved by the Committee on
Human Research at the University of California, San Fran-
cisco and the Institutional Review Board at the Children's
Hospital and Research Center Oakland.
Participant Recruitment
We recruited participants by direct mailings utilizing a
database of all general pediatricians in San Francisco (n =
113) maintained by the University of California, San
Francisco Division of General Pediatrics. This database is
continuously updated with names and contact informa-
tion of all general pediatricians in San Francisco. Addi-
tionally, we sent direct mailings to 2 large East Bay Area
practices. Participants were eligible if they were primary
care, office-based pediatric practitioners in full-time clini-
cal practice. According to standard qualitative design, pur-
posive sampling (deliberate selection of participants to
maximize demographic variability and minimize
response bias) was used to select participants with diverse
experiences and opinions. Participants were continuously
recruited and focus groups were conducted until content
saturation was achieved. Participants were provided din-
ner, an honorarium of $100 and educational materials
about CA-MRSA after completion of the focus group.
Funding for the focus groups was provided by the Univer-
sity of California, San Francisco, Division of General Pedi-
atrics.
Conducting the Focus Groups
In order to allow participants to share their viewpoints in
an unbiased manner, we developed a guide of open-
ended questions to assess the impact of CA-MRSA at the
community pediatrician level. The question guide was
based on a conceptual model developed specifically for
this study (Figure 1). The conceptual model was derived
from insight from a prior study about how patients with
SSTIs are managed in office settings [4], a pilot focus
group and our own clinical experiences. The guide
addressed three general topics (1) the clinical presenta-
tion and management of SSTIs and how this may have
changed since the emergence of CA-MRSA; (2) knowledge
and awareness of AAP/CDC treatment recommendations
and how they keep up to date about SSTIs; and (3) barriers
to providing recommended therapies. It was revised after
independent review by three investigators (ALH, MDC,
CSC), and testing with a pilot focus group.
Three semi-structured focus groups lasting one-hour
based on the question guide were moderated by one
investigator (CSC). The focus groups were recorded using
non-concealed microphones, participants were informed
that the transcripts would not contain personal identifiers
and they could refuse to answer any questions. A second
investigator (ALH) attended all focus groups to ensure
that all topics were covered and took notes on general
themes and participant reactions and interactions. Partic-
ipants were encouraged to express all viewpoints and to
respond to other participants' comments.BMC Pediatrics 2009, 9:27 http://www.biomedcentral.com/1471-2431/9/27
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Analysis
Audiotapes were transcribed verbatim except for removal of
identifying information. Two investigators (ALH, CSC)
independently reviewed the transcripts to minimize bias.
Initially, both investigators (who attended all focus groups)
discussed impressions, reviewed notes, and read all tran-
scripts to create a coding template of major themes that
arose during all three focus groups. Transcripts were then
reread by both investigators and using constant compara-
tive techniques based on grounded theory, participant
responses were independently coded into thematic catego-
ries. Coding by each investigator was then compared and
discordant classifications were discussed and resolved.
Results
Participants
Three focus groups of 8–11 participants were conducted
during January/February 2008. Participants included 28
pediatricians and 1 pediatric nurse practitioner (Table 1).
The major themes identified from the focus groups are
summarized in Table 2 and discussed below.
Changes in practice since emergence of CA-MRSA
Six themes emerged related to changes in clinical practice.
Bacterial Epidemiology
Most participants identified CA-MRSA as the most com-
mon cause of purulent SSTIs in their practices.
"I feel like they [cultures] all come back MRSA."
Clinical Presentation
Most participants felt that the incidence of purulent SSTIs
had recently increased due to CA-MRSA. However, there
was consensus that the severity of SSTIs had not changed
and that patients with CA-MRSA typically respond to
treatment. Two clinical features were highlighted as
important changes associated with CA-MRSA. The first
was patients with multiple recurrences and secondary
transmission to their household members.
"Just recurrence, recurrence, recurrence, where it's the same
kid, the same family, over and over again."
Conceptual model of the impact of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) on primary  care Figure 1
Conceptual model of the impact of community-associated methicillin-resistant Staphylococcus aureus (CA-
MRSA) on primary care. The top level reflects how CA-MRSA influences factors relating to diagnosis and presentation of 
SSTIs. The second level accounts for how trends in the epidemiology of SSTIs, barriers to implementing recommended thera-
pies and information/resources available to physicians influence the clinical management of SSTIs. SSTI, skin and soft-tissue 
infection.
CA-MRSA
Clinical Presentation
Bacterial 
Epidemiology Psychosocial Factors
Factors Influencing SSTI Diagnosis
Clinical Management of SSTIs
Diagnostic Testing Surgical Management Medical Management
Prevention & 
Follow-up
Trends and Barriers Information and 
ResourcesBMC Pediatrics 2009, 9:27 http://www.biomedcentral.com/1471-2431/9/27
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The second was increased SSTI incidence among infants,
especially in the form of pustulosis.
Nearly all participants reported that patient and family
fears about CA-MRSA is a major sentiment in their prac-
tices. Participants believed that this has been magnified by
recent media reports describing CA-MRSA as a "super-bug."
"Staph has been around for forever, but now it has a totally new
connotation. They automatically think it's life threatening. I
hear, "They have the 'Staph?' The Staph that's deadly?" And
[since] those major stories that have hit – everybody thinks
coming in with a little abscess ... it's going to be fatal."
Physicians reported that parent concerns were reinforced
by procedures required by patients' schools.
"Now I have to write notes saying that this kid can go back to
school with their staph infection."
Many reported that patient and family fears about CA-
MRSA were responsible for office visits for mild skin prob-
lems that would not have otherwise prompted medical
attention. Most felt that media reports were inaccurate
and exaggerated.
"It comes up all the time. People are always asking about it.
Every time there's some little scratch, they bring them in
because they're worried it's Staph."
Medical Management
All participants routinely prescribe oral antibiotics for
purulent SSTIs and stated that they prescribe antibiotics
independent of performing I&D. This practice preceded
the emergence of CA-MRSA.
"I always put them on an oral antibiotic. I don't leave it up to
God to do it."
Some reported that now they empirically prescribe antibi-
otics with activity against CA-MRSA (e.g. trimethoprim/
sulfamethoxazole or clindamycin) for patients with puru-
lent SSTIs whereas they previously used cephalexin, while
other participants still chose cephalexin as a first-line anti-
biotic. Participants were not aware of community rates of
resistance to these antibiotics and thus resistance data was
not an important factor in their antibiotic selection. For
cases of pustulosis in infants, some participants reported
prescribing only topical therapy with mupirocin.
Surgical Management
Owing to the increased incidence of purulent SSTIs in
their practices, some participants reported that they now
perform I&D more frequently, however, overall use of
I&D is low. There was variation in the perception of the
importance of I&D. Some participants questioned
whether this procedure was necessary for all patients,
especially if they had been treated with appropriate anti-
biotics.
"I believe a lot of these can be treated without I&Ding ... you're
giving antibiotics."
"I'll start them on something (antibiotics) and then follow-up.
I find that I'm able to sort of manipulate around it because it's
not that urgent."
Although a few participants perform I&D of deeper
lesions and use packing, most only perform very limited
procedures (e.g. a small incision or nick with a needle or
scalpel).
Diagnostic Testing
Most participants reported performing cultures of puru-
lent SSTIs routinely which is a change in practice due to
CA-MRSA.
"10 years ago I wouldn't culture on a routine basis ... I culture
everything now."
Participants mentioned that there are circumstances
where cultures are not routinely performed, such as recur-
rent infections or lesions that appear to be resolving. No
participants reported performing cultures for the benefit
of epidemiologic surveillance at the practice or commu-
nity level.
Prevention and Follow-up
Many participants expressed uncertainty about the bene-
fits of prevention measures, especially decolonization reg-
imens and reported frustration with the apparent lack of
consensus about their value.
"I feel like I'm going around in a circle, treat the family, don't
treat the family. I don't know what to do anymore."
Nonetheless, many participants reported prescribing
mupirocin for nasal decolonization for index patients and
their family members, especially in cases of recurrences.
Table 1: Demographic and practice characteristics of study 
participants (total N = 29).
Characteristic Number (%)
Male 9 (31)
Mean age in years (range) 44 (29–72)
Mean years practice (range) 14 (2–43)
Practice Setting
Private practice 20 (69)
University practice 3 (10)
Health maintenance organization 3 (10)
Community health clinic 3 (10)BMC Pediatrics 2009, 9:27 http://www.biomedcentral.com/1471-2431/9/27
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Many participants noted that managing patients with CA-
MRSA is extremely time consuming. They noted spending
significant time addressing parental fears, answering ques-
tions and explaining decolonization regimens. Although
only a few mentioned emphasizing personal and environ-
mental hygiene, those that did indicated that it also was
very time-consuming. Many participants mentioned that
due to CA-MRSA, they now routinely arrange for their
patients to follow-up within 24 hours after treatment ini-
tiation. This is a recent change in practice.
"In the past I would never follow-up a regular abscess. Now I
always have them come back, no matter what."
Knowledge about current SSTI treatment 
recommendations and how to stay updated
There is very limited awareness of recently published SSTI
treatment recommendations. Only 1 of 29 participants
was aware of the CDC recommendations and 1 was aware
of the AAP recommendations.
For resources about local epidemiology, most participants
were aware of hospital antibiograms (cumulative reports
of antibiotic susceptibility for bacteria). However, there
was consensus that this information is not helpful for
treating their patients with SSTIs because they do not
believe it is a valid reflection of their outpatient popula-
tion. There was strong desire to receive more clinically rel-
evant antibiograms based on outpatient cultures and
sorted by specimen type (e.g. abscess, urine etc).
Participants mentioned many resources they use to stay
updated about treatment recommendations (Table 3).
Most participants rely on electronic sources including
journals and websites. Several indicated that they value
input from infectious disease specialists but have limited
access to them.
Barriers to compliance with current recommendations
Participants mentioned multiple barriers that make
adherence to treatment recommendations challenging.
These included both internal barriers (related to personal
levels of knowledge, attitude and skills) and external bar-
riers (related to the healthcare system) [13].
Medical management
In terms of recommendations to target CA-MRSA with
antibiotic therapy, participants mentioned a variety of
external barriers limiting willingness to adhere to this rec-
ommendation. These include concerns about compliance
with antibiotic therapy (related to taste and dosing fre-
quency), cost and insurance coverage, desire for Group A
Streptococcus coverage, promoting further resistance and
causing adverse drug events (e.g. Clostridium difficile colitis
and Stevens-Johnson Syndrome). Additionally, some felt
that their limited experience using trimethoprim/sulfam-
Table 2: Summary of major themes identified about the impact of CA-MRSA on primary care pediatric practices for SSTIs.
Themes
How has your practice changed since the emergence of CA-MRSA?
Bacterial Epidemiology Majority is CA-MRSA.
Clinical Presentation Increased case numbers but not severity.
Increased recurrences, household transmission and incidence among 
infants.
Substantial patient fear of CA-MRSA.
Clinical Management
Medical Management Antibiotics are highly important and routinely prescribed.
Some increased empiric prescribing of antibiotics that treat CA-MRSA.
Surgical Management Variable perception of importance of I&D.
Diagnostic Testing Increased use of bacterial culture.
Prevention and Follow-up More aggressive follow-up.
Uncertainty about role of decolonization.
What is your knowledge about SSTI treatment recommendations and 
how do you stay updated?
Limited awareness of published recommendations from CDC and AAP.
What are the barriers to compliance with current recommendations?
Internal Barriers
Lack of awareness of current guidelines.
Inexperience with antibiotics that treat CA-MRSA.
Lack of self-efficacy with I&D.
Skepticism about treatment with I&D alone.
External Barriers
Concerns about antibiotic compliance.
Lack of epidemiologic data about resistance patterns for SSTIs.
Lack of resources to perform office I&D.
Delays in receiving culture results.BMC Pediatrics 2009, 9:27 http://www.biomedcentral.com/1471-2431/9/27
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ethoxazole and clindamycin contributed to reluctance to
prescribe these medications. The lack of readily available
data about the epidemiology of SSTIs, including rates of
resistance to specific antibiotics (e.g. clindamycin) in the
community is also felt to be an important barrier to
adopting this recommendation.
Surgical management
Several barriers to performing office I&D were shared by
participants. Many of these are external and relate to sys-
tem-based challenges inherent to performing a procedure
in a busy office practice. These include inadequate time in
the schedule and insufficient resources or personnel to
provide pain control and sedation, gather supplies and to
hold the patient.
"It (I&D) puts you behind."
Several participants mentioned a lack of training and lim-
ited expertise in performing I&D as an important internal
barrier.
"Why not put it in the hands of somebody who does a lot of
I&Ds."
"I don't feel like I'm good at it."
Further, some participants are uncomfortable performing
invasive procedures in the office because it conflicts with
parent expectations of an outpatient office setting (vs.
another setting such as an emergency department).
"...you're trying to I&D a 2 year old who's screaming. That
spreads out to the other patients and it's an inappropriate thing
to do."
"I think it's tough for the relationship with the kid doing those
things (I&D)."
On the other hand, a few participants felt strongly about
performing the procedure themselves because they
believed that other physicians may not appreciate the
unique needs of children.
In terms of the recommendation to treat some purulent
SSTIs with I&D alone, several participants were skeptical
about applying this strategy in routine practice.
"You pick up Time Magazine and they're saying more people
are going to die of MRSA than HIV in the next 10 years. It
makes it hard to feel comfortable just draining it."
Diagnostic testing
Participants mentioned that there are barriers related to
performing and using culture results. In some cases, par-
ticipants are concerned about the additional cost to their
patients while others mentioned that delays exceeding 2–
3 days in receiving culture results are common. Others
reported that not all laboratories perform D-testing for
inducible clindamycin resistance. Most participants noted
that the follow-up for cultures is labor-intensive.
"It's more work – culturing and calling and following-up and
making sure they're on the right medicine."
Discussion
We found that the emergence of CA-MRSA has influenced
multiple factors related to the diagnosis and clinical man-
agement of SSTIs in ambulatory pediatrics. Additionally,
we found that there were both internal and external barri-
ers [13] to adoption of recommended therapies for SSTIs
and opportunities to improve care. Our findings highlight
the complex issues facing physicians when a new disease
emerges that generates public attention, affects a large
number of patients and requires changes in practice.
This is the first study to explore the significance of CA-
MRSA in primary care pediatrics in terms of the impact it
has had on clinical practice. The qualitative design of our
study enabled us to probe with great depth around issues
faced by primary care physicians and their practice pat-
terns. Similar to national trends, our participants reported
increased patient visits due to SSTIs caused by CA-MRSA
[4]. As a consequence, some of the challenges identified
related to increased time demands in terms of changes in
how pediatricians manage children with SSTIs in the CA-
MRSA era. This includes time for more follow-up visits,
Table 3: Important sources of information and resources about management of skin and soft-tissue infections.
Electronic sources
Peer reviewed and non-peer reviewed journals
Peer reviewed websites (e.g. UpToDate)
MD Consult
SERMO
Non-peer reviewed print journals (e.g. Infectious Diseases in Children)
Television and print media
Infectious Disease consultants
Health Department bulletins
Grand Rounds, Continuing Medical EducationBMC Pediatrics 2009, 9:27 http://www.biomedcentral.com/1471-2431/9/27
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following up on culture results and time requirements for
explaining decolonization regimens to families. Addition-
ally, non-medical burdens were noted such as frustration
about the lack of evidence-based strategies for preventing
recurrences and household transmission as well as time
demands to address questions and concerns about CA-
MRSA among patients and their families.
Addressing these challenges faced by primary care pedia-
tricians is crucial to informing the design of future inter-
ventions focused on treatment and prevention of CA-
MRSA.
Participants in our study believe that fear induced by
media coverage of CA-MRSA caused increased visits for
mild skin problems. We did not directly ascertain from
our participants whether they felt pressure to prescribe
antibiotics for mild infections, however, participants
reported using antibiotics frequently and substantially
increasing the number of cultures they performed. The
potential for media to influence physician behavior was
highlighted in a prior study showing a strong association
between media reports of invasive group A streptococcus
infection and testing for GAS in a pediatric ED [14].
The potential for "disease mongering" (expansion of the
market for a disease) exists because of the broad spectrum
of severity for CA-MRSA ranging from life-threatening
(invasive infections) to mild (most SSTIs) to none
(asymptomatic colonization). Media reports prompted by
severe infections may "blur the distinction between mild
and severe," which is a key component of this phenome-
non [15]. Determining whether the observations noted by
our participants are representative of national trends will
further our understanding of how the media can influence
patient use of ambulatory services and subsequent physi-
cian behavior. Gaining more direct insight into how com-
munication from schools to parents about CA-MRSA
influences office visits is important since our participants
noted that schools also contributed to parental fears and
concerns. Additionally, the impact of new legislation
mandating MRSA screening for hospital admissions in
many states (including California) on public perceptions
about MRSA remains unknown.
Our participants felt strongly about prescribing antibiotics
for SSTIs, independent of whether or not I&D is per-
formed. Although current recommendations suggest that
some patients can be treated with I&D alone, our results
indicate reluctance among primary care pediatricians to
adopt this practice. Some of the reluctance to limit antibi-
otic use may stem from the challenges faced by primary
care pediatricians to performing adequate I&D in office
settings including internal barriers such as a lack of self-
efficacy and guideline agreement. Additionally, external
barriers such as inadequate time and supplies and inabil-
ity to provide adequate pain control or sedation also seem
to influence their practice. Our participants did not explic-
itly cite reimbursement as a barrier to performing I&D,
however, reimbursement has been previously shown to be
a barrier to guideline adherence [16]. Participants were
concerned about the time and supplies that are required,
issues that could impact reimbursement by increasing
overhead or decreasing patient flow in a busy office prac-
tice. Designing interventions to increase use of I&Ds for
purulent SSTIs is important because for some patients,
failure to perform a prompt I&D may delay resolution of
the infection.
Some participants in our study did not target CA-MRSA
with their initial empiric antibiotic. Although the optimal
antibiotic therapy for purulent SSTIs is unknown, experts
have suggested using a 10% community prevalence as a
threshold above which to empirically treat with an antibi-
otic active against CA-MRSA and this was validated using
a decision-analytic model [11,17]. Our prior work [4] has
shown that cephalexin remains commonly prescribed for
SSTIs despite the fact that CA-MRSA prevalence in most
communities is >10%. Participants in our study felt that
they did not have access to epidemiologic data about bac-
terial infections and antibiotic resistance patterns in their
community. Because physician education has been shown
to improve antibiotic selection [18], it is possible that
direct dissemination of epidemiologic data about SSTIs to
pediatricians would address this barrier and could influ-
ence their prescribing.
Most of the participants in our study were unaware of
recent SSTI treatment recommendations. Since guidelines
are more credible to physicians when developed by their
own specialty organization [19] and the AAP recently
published SSTI treatment recommendations, this is espe-
cially concerning. The lack of awareness among our partic-
ipants of guidelines about a condition that significantly
impacts on their practice suggests that more effective
methods of dissemination must be identified.
The practice patterns reported by our participants are sim-
ilar to prior studies of patterns of care for SSTIs showing
high rates of antibiotic prescribing, including increased
use of antibiotics active against CA-MRSA. In a study using
nationally representative office visit data, >75% of chil-
dren with SSTIs received an antibiotic and use of antibiot-
ics active against CA-MRSA had increased substantially by
2005 [4]. On the other hand, studies examining I&D use
have shown low utilization in ambulatory settings
[20,21]. A recent survey of pediatric infectious disease spe-
cialists reported that 100% recommended antibiotics for
SSTIs and many used decolonization regimens, although
there was significant variability in antibiotic selection and
decolonization methods [22]. Although this variability is
an area of concern for our participants, it is notable thatBMC Pediatrics 2009, 9:27 http://www.biomedcentral.com/1471-2431/9/27
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the primary prevention strategy recommended by the
CDC which emphasizes personal hygiene including hand
washing and not sharing personal items was only men-
tioned by a small number of participants. The CDC
recently launched an MRSA Education Campaign (availa-
ble at http://www.cdc.gov/MRSA/) which will hopefully
increase awareness among both health care providers and
parents about recognition and prevention of SSTIs caused
by CA-MRSA by providing educational materials.
There are several limitations to our study. First, our partic-
ipants were selected from one urban geographic region
and their experiences and opinions may not be generaliz-
able to other communities, including rural areas or those
where CA-MRSA is not endemic. Although we used pur-
posive sampling to enhance generalizability and to mini-
mize response bias, it is possible that the study
participants' experiences differed from other pediatricians
in the region. Although pediatricians provide the majority
of pediatric primary care in the United States [23], because
we did not include family physicians and emergency
department physicians in the study it is unknown whether
our findings are applicable to these specialties. Despite
these potential limitations, we believe these findings are
relevant to primary care physicians nationwide since we
included participants from a variety of clinical settings
and recent data indicates that SSTIs have increased
throughout the country and present most frequently to
primary care offices [4].
Conclusion
Our findings have implications for patient care, health-
care systems and development of SSTI treatment guide-
lines. Efforts are necessary to improve the dissemination
of recommendations focusing on treatment and preven-
tion strategies from the CDC and the AAP to the front-line
physicians they are intended to reach. This study suggests
also that endorsement by and access to infectious disease
specialists and distribution of epidemiologic data focus-
ing on ambulatory patients could promote uptake of new
guidelines for SSTIs. Given that most participants were
reluctant to not prescribe antibiotics, there is an urgent
need to conduct studies rigorously evaluating whether or
not antibiotics are necessary for uncomplicated SSTIs and
indentifying which patients can be safely treated with I&D
alone. Studies evaluating the effectiveness of prevention
interventions including decolonization and hygiene are
also crucial in order to prevent recurrent and secondary
infections which are key drivers of the CA-MRSA epi-
demic. Additionally, it is necessary to address barriers that
interfere with provision of recommended therapies for
SSTIs, especially performing I&D. Time constraints and
office resources could potentially be addressed by ambu-
latory procedure clinics. Internal barriers of self-efficacy
and knowledge could be addressed through enhanced
training opportunities during residency or as continuing
education. Our study highlights the complex barriers in
improving physician adherence to practice guidelines,
especially for practice recommendations targeted at
emerging and highly publicized diseases.
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